Previous Close | 21.09 |
Open | 21.09 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 21.09 - 21.09 |
52 Week Range | 14.02 - 22.00 |
Volume | |
Avg. Volume | 75 |
Market Cap | 6.787B |
Beta (5Y Monthly) | 0.57 |
PE Ratio (TTM) | 23.18 |
EPS (TTM) | 0.91 |
Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ALAMEDA, Calif., May 07, 2024--Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following investor conferences in May:
As you might know, Exelixis, Inc. ( NASDAQ:EXEL ) last week released its latest quarterly, and things did not turn out...
ALAMEDA, Calif., April 30, 2024--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated commercial, clinical and pipeline development milestones.